New Feature:   See every earnings report in one clear view

Try it now

This Dividend Aristocrat Posted Record Quarterly Results

By Derek Lewis | August 14, 2026, 7:41 PM

Everybody loves dividends, as they provide a passive income stream, limit drawdowns in other positions, and provide more than one way to profit from an investment.

And when considering dividend-paying stocks, those with a history of boosting their payout are prime considerations, reflecting their commitment to increasingly rewarding shareholders.

And when it comes to a consistent history of increased payouts, look no further than the Dividend Aristocrats.

Johnson & Johnson JNJ fits the criteria nicely.

Johnson & Johnson Outperforms

Johnson & Johnson shares have quietly delivered a huge gain in 2026 so far, up more than 25%. The gain has similarly shown strong outperformance relative to the S&P 500, with recent results driving positive momentum post-earnings.

Sales of $25.3 billion reflected a new quarterly record for the company, growing by a solid 6.6% year-over-year. It also increased both its current fiscal year sales and adjusted EPS guidance, with JNJ now on track to meet its 2026 target of more than $100 billion in annual revenue for the first time in its history.

Below is a chart illustrating the company’s dividends/share on a quarterly basis.

Zacks Investment Research

Image Source: Zacks Investment Research

Bottom Line

Everybody loves dividends, essentially investors’ form of payday. They can help limit drawdowns in other positions and provide an income stream, two key traits that all market participants enjoy.

And for those seeking companies with a consistent history of steady payouts, Johnson & Johnson JNJ fits the criteria.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Johnson & Johnson (JNJ): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Mentioned In This Article

Latest News